Microbiology

The Manager Drug Safety Content Analysis will manage and supervise project’s PV Operations/training staff on a day-to-day basis, guiding performance of PV Operations staff in ongoing projects in terms of training, quality of deliverables, compliance with the timelines and relevant trainings.

handle R&D projects independently in the areas of epidemiology, big data analytics, drug/ target/ biomarker discovery, preclinical and clinical evaluation of medical devices, IVDs, therapies, vaccines, field feasibility studies of the novel interventions, and experience/ exposure to regulatory aspects of health technologies, IP protection, Technology transfer. Health policy development and implementation. MD, MS or equivalent degree recognised by MCI, NMC OR MBBS or equivalent degree recognized by MCI, NMC, with MPH from a recognised university OR M.Sc or MBBS or equivalent degree, recognised by MCI, NMC, with Ph.D. from a recognised University.

Write brief narratives summarizing the ICSR criteria and other potentially safety-relevant information in each article. Demonstrates understanding of client’s drugs labels and uses that knowledge effectively when performing the safety assessments.

Exposure to aseptic process activities, aseptic techniques, aseptic filling and sealing activities, and media filling activities. Experience in operating autoclaves and terminal sterilizers. Preparation of autoclave loads, loading and unloading of autoclaves and sterilizers

The candidate will work in the areas of biocatalysis, enzyme engineering and applied microbiology. Biocatalytic Manufacturing of Industrially Important Enantiopure β-Amino Acids. Masters degree in Microbiology, Biochemistry, Biotechnology, Microbial Biotechnology, Industrial Biotechnology, Pharmaceutical BioTechnology, Biochemical Engineering.

2 years of experience of working in a molecular diagnostic laboratory for candidates with M.Sc, B.Tech in the above subjects. 1 year experience for candidates with Phd in the above subjects. Candidates with experience of working in a molecular diagnostic laboratory or accredited labs or those labs who have applied for accreditation will be preferred.

If the number of JRF and INSPIRE qualified candidates are large, selection will be based on interview of the JRF and INSPIRE qualified candidates only. The selected candidates will be registered for BRIC-DBT-RCB-Ph.D programme and he/she can be placed in any centres of the IBSD

In vitro and in vivo evaluation of liposome encapsulated Mycobacteriophages D29 and TM4 as therapeutic candidates against Mycobacterium tuberculosis. The candidate must have First class post graduate degrees or second class post graduate with PhD degree in relevance to nano technology, nano-delivery, biological therapeutics, pharmaceutical sciences, Biotechnology, Desirable experience: PhD thesis submitted or having Research fellow experience or having previous experience in nano/liposomal formulation, stability and characterization. PG degrees in Microbiology / Biotechnology / Biomedical Science, with three years experience or PhD in Microbiology / Biotechnology / Biomedical Science